Sign in
4

Changes in Ownership

ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-24-026871

See Remarks sold 4,046 shares at $23.35 ($94,474)

  • See Remarks acquired 103,194 shares (other)
  • See Remarks acquired 9,543 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Patel Kinnari See Remarks 2024-05-14 Option exercise +3,990 296,291 D: show line 1 in the form
Patel Kinnari See Remarks 2024-05-14 Option exercise +5,553 301,824 D: show line 2 in the form
Patel Kinnari See Remarks 2022-02-14 Other acquisition +11,970 313,794 D: show line 3 in the form
Patel Kinnari See Remarks 2022-08-12 Other acquisition +52,489 366,283 D: show line 4 in the form
Patel Kinnari See Remarks 2023-02-14 Other acquisition +38,735 405,018 D: show line 5 in the form
Patel Kinnari See Remarks 2024-05-16 Sale −4,046 $23.35 $94,474 400,972 D: show line 6 in the form
Open-market sales · 4,046 sh · avg $23.35 · $94,474

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Patel Kinnari See Remarks 2024-05-14 Option exercise · Restricted Stock Units −3,990 11,970 D: show line 7 in the form
Patel Kinnari See Remarks 2024-05-14 Option exercise · Restricted Stock Units −5,533 38,735 D: show line 8 in the form
Patel Kinnari See Remarks 2022-02-14 Other disposition · Restricted Stock Units −11,970 0 D: show line 9 in the form
Patel Kinnari See Remarks 2022-08-12 Other disposition · Restricted Stock Units −52,489 0 D: show line 10 in the form
Patel Kinnari See Remarks 2023-02-14 Other disposition · Restricted Stock Units −38,735 0 D: show line 11 in the form
Loading xslF345X05/form4.xml…